Advertisement
News
Advertisement

Prexa Pharma raises $3.2M to target ADHD, depression, Parkinson's

Fri, 04/29/2011 - 9:38am
Mass High Tech: The Journal of New England Technology

Boston’s Prexa Pharmaceuticals Inc. has brought in $3.25 million of a $7 million equity round, according to a filing with the U.S. Securities and Exchange Commission.

The company, founded in 2006 according to its website, is developing small molecule monoamine reuptake inhibitors focused on enhancing dopamine activity with the goal of improving on treatments for central nervous system disorders ADHD, depression and Parkinson’s disease.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading